Daratumumab Antibody, CAS [[945721-28-8]], Unconjugated

Produktübersicht

• Artikelname: Daratumumab Antibody, CAS [[945721-28-8]], Unconjugated
• Artikelnummer: BYT-ORB1297797
• Hersteller Artikelnummer: orb1297797
• Alternativnummer: BYT-ORB1297797-1, BYT-ORB1297797-10, BYT-ORB1297797-100, BYT-ORB1297797-25, BYT-ORB1297797-5, BYT-ORB1297797-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Konjugation: Unconjugated
• Alternative Synonym: cytotoxicity, Daratumumab, cell, adhesion, ADC Antibody, ADCAntibody, antibody, Anti-Human CD38, Human Antibody, FcR, Inhibitor, inhibit, myeloma, tumor

Produktbeschreibung

Daratumumab is a human IgG1kappa monoclonal antibody that specifically binds to the CD38 glycoprotein, which is highly expressed on malignant plasma cells in multiple myeloma. It is widely used in both in vitro and in vivo research to study mechanisms of antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) against myeloma cells.

Produkteigenschaften

• Konzentration: 22 mg/mL
• Molekulargewicht: Approximately 148kDa
• Reinheit: 98.60% (May vary between batches)
• CAS Nummer: [945721-28-8]
• Target-Kategorie: ADC Antibody,CD38